Company / Cost of Revenue
Pulmonx Corp Cost of Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$21.8M
FY2025
5-year range
$11.5M / $21.8M
FY2021-FY2025
Trend
+21.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 5 consecutive years, from $8M in FY2020 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +23.1%.
Increased from $14M to $22M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +19.4%
- 5-Year CAGR
- +23.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Pulmonx Corp's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +23.1%, indicating consistent growth.
- In FY2025, cost of revenue increased 21.6% year-over-year.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.8M | +21.6% |
| FY2024 | $17.9M | +29.9% |
| FY2023 | $13.8M | +7.9% |
| FY2022 | $12.8M | +10.9% |
| FY2021 | $11.5M | +49.4% |
| FY2020 | $7.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026